10 3 / 2012

Mar 9, 2012

 Republicans in Kansas want what would in effect be a sales tax on women seeking abortion. According to the Huffington Post “under the proposal, women who end up receiving abortions would not be able to deduct the cost of the abortion as a health care expense if they had not purchased special abortion insurance…”.* Ana Kasparian and former prosecutor Steve Oh discuss on The Young Turks.

http://www.huffingtonpost.com/2012/03/08/kansas-abortion-bill-sales-tax_n_132…

Subscribe to The Young Turks: http://bit.ly/eWuu5i

Posted via email from Cynthia’s News Posterous | Comment »

12 11 / 2011

Clinical_trials_lg

Medical Clinical Trial of Medicine Results

Results of the PROFI study reported at TCT 2011 - http://goo.gl/bsse1 Results from the PROFI study indicate that the use of a proximal balloon occlusion in carotid artery stenting lead to fewer cerebral ischemic lesions – a predictor of stroke – than with the use of a filter. Trial results were presented today at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
##
Results of the ADVISE trial reported at TCT 2011 - http://goo.gl/s7jk3 Researchers conducting the ADVISE clinical trial have concluded that a new measure of stenosis severity, instantaneous wave-free ratio (iFR), yielded similar results to traditional fractional flow reserve (FFR) without the use of adenosine to induce maximum hyperemia. Trial results were presented today at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
##

Medicine

Results of the TWENTE trial reported at TCT 2011 - http://goo.gl/eEFhc The TWENTE clinical trial, which compared two second generation drug-eluting stents – zotarolimus and everolimus-eluting stents – established non-inferiority between the two stents as measured by the primary endpoint: target vessel failure (TVF) at one year. Both stents also demonstrated low rates of stent thrombosis. Trial results were presented today at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
##
Results of the COBRA trial reported at TCT 2011 - http://goo.gl/07GGU A clinical trial of patients with diabetes has demonstrated that cryoplasty post-dilitation compared to conventional balloon angioplasty in the superficial femoral artery (SFA) decreased the risk of in-stent restenosis (ISR). Results from the COBRA clinical trial were presented today at the 23rd Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
##
Results of the REMEDEE trial reported at TCT 2011 - http://goo.gl/UVb9b A randomized comparison of a dual therapy stent – which combines low-dose sirolimus delivery from an abluminal biodegradable polymer matrix with a covalently bound anti-CD34 antibody layer – with a paclitaxel-eluting stent showed that the dual therapy stent effectively controls neointimal proliferation and was shown to be safe and effective. Results of the REMEDEE trial were presented today at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
##
Medicine2

Results of the ROTAXUS trial reported at TCT 2011 - http://goo.gl/R1m1W A clinical trial testing the efficacy of rotational atherectomy (or rotablation, a process of drilling through plaque deposits) prior to implantation of a drug-eluting stent found that the process was not superior to standard balloon angioplasty and decreased the efficacy of the stent in reducing new tissue growth within the blood vessel.
##
Results of the EVOLVE trial reported at TCT 2011 - http://goo.gl/8za4j A clinical trial has established the non-inferiority of a drug-eluting stent with a bioabsorbable polymer compared to a drug-eluting stent with a durable polymer. Results of the EVOLVE clinical trial were presented today at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

Source MedicalXPress.com their source Cardiovascular Research Foundation

Posted via email from Cynthia’s News Posterous | Comment »